Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherPDA Paper

CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil and Anil Sawant
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: https://doi.org/10.5731/pdajpst.2020.012021
Anthony M Cundell
1 Microbiological Consulting, LLC;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tonycundell@gmail.com
Dennis Edward Guilfoyle
2 Johnson & Johnson;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dguilfoy@its.jnj.com
T. R. Kreil
3 Takeda, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Sawant
4 Merck & Co., Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anil.sawant@merck.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2020.012021
DOI 
https://doi.org/10.5731/pdajpst.2020.012021
PubMed 
32467176

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received May 22, 2020
  • Accepted May 22, 2020
  • Published online May 28, 2020.

Article Versions

  • You are currently viewing a previous version of this article (May 28, 2020 - 09:03).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020, Parenteral Drug Association

Author Information

  1. Anthony M Cundell1,5 (tonycundell{at}gmail.com),
  2. Dennis Edward Guilfoyle2 (dguilfoy{at}its.jnj.com),
  3. T. R. Kreil3 and
  4. Anil Sawant4 (anil.sawant{at}merck.com)
  1. 1 Microbiological Consulting, LLC;
  2. 2 Johnson & Johnson;
  3. 3 Takeda, Vienna, Austria;
  4. 4 Merck & Co., Inc.
  1. ↵* Corresponding author; email: tonycundell{at}gmail.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 75 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 75, Issue 1
January/February 2021
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC
Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil, Anil Sawant
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: 10.5731/pdajpst.2020.012021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC
Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil, Anil Sawant
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: 10.5731/pdajpst.2020.012021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Lessons from a Pandemic: Maintaining Compliant GxP Surveillance Programs and Stable Pharmaceutical Supply
  • Google Scholar

More in this TOC Section

  • Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review
  • Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations
Show more PDA Paper

Similar Articles

Keywords

  • COVID-19 pandemic
  • SARS-CoV-2
  • Drug shortage
  • Risk assessment
  • Risk mitigation
  • Supply chain

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2021 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire